ENST00000513995.1:n.160A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000513995.1(DOK7):​n.160A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0221 in 1,549,666 control chromosomes in the GnomAD database, including 689 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 77 hom., cov: 34)
Exomes 𝑓: 0.022 ( 612 hom. )

Consequence

DOK7
ENST00000513995.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.09

Publications

2 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 4-3485508-A-G is Benign according to our data. Variant chr4-3485508-A-G is described in ClinVar as Benign. ClinVar VariationId is 262879.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0208 (3159/152234) while in subpopulation NFE AF = 0.0251 (1705/67992). AF 95% confidence interval is 0.0241. There are 77 homozygotes in GnomAd4. There are 1736 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 77 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOK7NM_173660.5 linkc.533-31A>G intron_variant Intron 4 of 6 ENST00000340083.6 NP_775931.3 Q18PE1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOK7ENST00000340083.6 linkc.533-31A>G intron_variant Intron 4 of 6 1 NM_173660.5 ENSP00000344432.5 Q18PE1-1

Frequencies

GnomAD3 genomes
AF:
0.0208
AC:
3161
AN:
152116
Hom.:
77
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00323
Gnomad AMI
AF:
0.0439
Gnomad AMR
AF:
0.0112
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.0996
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0251
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0229
AC:
5060
AN:
220642
AF XY:
0.0226
show subpopulations
Gnomad AFR exome
AF:
0.00286
Gnomad AMR exome
AF:
0.00561
Gnomad ASJ exome
AF:
0.00284
Gnomad EAS exome
AF:
0.0000688
Gnomad FIN exome
AF:
0.102
Gnomad NFE exome
AF:
0.0243
Gnomad OTH exome
AF:
0.0237
GnomAD4 exome
AF:
0.0223
AC:
31111
AN:
1397432
Hom.:
612
Cov.:
30
AF XY:
0.0219
AC XY:
15115
AN XY:
690442
show subpopulations
African (AFR)
AF:
0.00254
AC:
78
AN:
30744
American (AMR)
AF:
0.00633
AC:
250
AN:
39472
Ashkenazi Jewish (ASJ)
AF:
0.00273
AC:
67
AN:
24526
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35828
South Asian (SAS)
AF:
0.00462
AC:
363
AN:
78608
European-Finnish (FIN)
AF:
0.100
AC:
5151
AN:
51290
Middle Eastern (MID)
AF:
0.00398
AC:
22
AN:
5528
European-Non Finnish (NFE)
AF:
0.0225
AC:
24170
AN:
1074212
Other (OTH)
AF:
0.0176
AC:
1010
AN:
57224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1527
3053
4580
6106
7633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
874
1748
2622
3496
4370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0208
AC:
3159
AN:
152234
Hom.:
77
Cov.:
34
AF XY:
0.0233
AC XY:
1736
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00322
AC:
134
AN:
41552
American (AMR)
AF:
0.0112
AC:
171
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00353
AC:
17
AN:
4822
European-Finnish (FIN)
AF:
0.0996
AC:
1058
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0251
AC:
1705
AN:
67992
Other (OTH)
AF:
0.0123
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
144
288
431
575
719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0158
Hom.:
17
Bravo
AF:
0.0137
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
2.6
DANN
Benign
0.80
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181786949; hg19: chr4-3487235; API